SCHEMBL10033988

SCHEMBL10033988

CC1(C)C(=O)CC[C@@]2(C)C1CC(=O)[C@@]1(C)C3=CC(=O)O[C@@H](c4ccoc4)[C@]3(C)CCC12

nearest known ligand 0.71

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 12/20 0.71
▸ SLCO1B3 Q9NPD5 8/20 0.71
▸ SLCO1B1 Q9Y6L6 8/20 0.71
▸ TP53 P04637 5/20 0.71
▸ USP2 O75604 7/20 0.64
▸ SMN1; SMN2 Q16637 5/20 0.64
▸ ALDH1A1 P00352 4/20 0.50
▸ MAPT P10636 3/20 0.50
▸ TDP1 Q9NUW8 2/20 0.50
▸ MEN1 O00255 1/20 0.49
▸ KMT2A Q03164 1/20 0.49
▸ HSD17B10 Q99714 1/20 0.49
▸ HPGD P15428 1/20 0.47
▸ MAPK1 P28482 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12998468 0.83 CYP3A4 (1.00) CYP3A4SLCO1B3SLCO1B1TP53USP2
SCHEMBL12998455 0.82 CYP3A4 (0.63) CYP3A4SLCO1B3SLCO1B1TP53USP2
SCHEMBL15414716 0.78 CYP3A4 (1.00) CYP3A4SLCO1B3SLCO1B1TP53USP2
SCHEMBL25034707 0.72 CYP3A4 (0.70) CYP3A4SLCO1B3SLCO1B1TP53USP2
SCHEMBL13456007 0.70 CYP3A4 (0.80) CYP3A4SLCO1B3SLCO1B1TP53USP2
SCHEMBL10019477 0.68 CYP3A4 (0.77) CYP3A4SLCO1B3SLCO1B1TP53USP2
SCHEMBL800981 0.68 CYP3A4 (1.00) CYP3A4SLCO1B3SLCO1B1TP53USP2
SCHEMBL10019460 0.68 CYP3A4 (1.00) CYP3A4SLCO1B3SLCO1B1TP53USP2
SCHEMBL14196982 0.68 CYP3A4 (1.00) CYP3A4SLCO1B3SLCO1B1TP53USP2
3Beta,7Beta-Diacetoxydeoxodeacetoxydeoxydihydrogedunin SCHEMBL13424818 0.67 CYP3A4 (1.00) CYP3A4SLCO1B3SLCO1B1TP53USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120157474-A1 Methods of Identifying and Using General or Alternative Splicing Inhibitors THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2012-06-21 — — US disclosed
Send feedback